ScienceDex / Researcher record
Daniel A. Haber
- Massachusetts General Hospital · Internal Medicine (investigator's affiliation)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
- Mentor
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $2,090,818 | 4 | #4,944 |
| 2025 | $2,154,541 | 4 | #5,928 |
| 2026 | $731,872 | 2 | #24,658 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20244 records
- FY2025 · selected4 records
- FY20262 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1882057Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0003-1378-6551Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2025 award records by amount
NIH award records listing Daniel A. Haber as a PI. Multi-PI records show the full award amount for context.
- 5R01CA255602-05R01Co-investigatorHigh-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cellsMassachusetts General Hospital · Surgery (investigator's affiliation)$647.6Kaward amount
- 5T32CA071345-28T32Contact PITraining Program in Cancer Biology and TherapeuticsMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$633.5Kaward amount
- 5R01CA260304-05R01Co-investigatorMicrofluidic sorting of lung cancer cells from leukapheresis product as an alternative to metastatic tumor biopsyMassachusetts General Hospital · Surgery (investigator's affiliation)$453.4Kaward amount
- 5R01CA129933-18R01Contact PIModeling Metastasis and Acquired Drug Resistance Using Circulating Tumor CellsMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$420Kaward amount
Award organization
Organizations that administered FY2025 awards listing Daniel A. Haber as a PI.
FY2025 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4944
- 2024Entered Top 25% NationallyRanked #4944
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Daniel A. Haber.